@article{WOS:000684594500007,
 abstract = {A precise sequence of axon guidance events is required for the
development of the ocular motor system. Three cranial nerves grow
toward, and connect with, six extraocular muscles in a stereotyped
pattern, to control eye movements. The signaling protein
alpha2-chimaerin (alpha 2-CHN) plays a pivotal role in the formation of
the ocular motor system; mutations in CHN1, encoding alpha 2-CHN, cause
the human eye movement disorder Duane Retraction Syndrome (DRS). Our
research has demonstrated that the manipulation of alpha 2-chn signaling
in the zebrafish embryo leads to ocular motor axon wiring defects,
although the signaling cascades regulated by alpha 2-chn remain poorly
understood. Here, we demonstrate that several cytoskeletal regulatory
proteins-collapsin response mediator protein 2 (CRMP2; encoded by the
gene dpysl2), stathmin1, and stathmin 2-bind to alpha 2-CHN. dpysl2,
stathmin1, and especially stathmin2 are expressed by ocular motor
neurons. We find that the manipulation of dpysl2 and of stathmins in
zebrafish larvae leads to defects in both the axon wiring of the ocular
motor system and the optokinetic reflex, impairing horizontal eye
movements. Knockdowns of these molecules in zebrafish larvae of either
sex caused axon guidance phenotypes that included defasciculation and
ectopic branching; in some cases, these phenotypes were reminiscent of
DRS. chn1 knock-down phenotypes were rescued by the overexpression of
CRMP2 and STMN1, suggesting that these proteins act in the same
signaling pathway. These findings suggest that CRMP2 and stathmins
signal downstream of alpha 2-CHN to orchestrate ocular motor axon
guidance and to control eye movements.},
 affiliation = {Guthrie, S (Corresponding Author), Univ Sussex, Sch Life Sci, Brighton BN7 9QG, E Sussex, England.
Carretero-Rodriguez, Luis; Gudjonsdottir, Ragnheidur; Reilly, Madeline Louise; Guthrie, Sarah, Univ Sussex, Sch Life Sci, Brighton BN7 9QG, E Sussex, England.
Poparic, Ivana; Chol, Mary, Kings Coll London, Dept Dev Neurobiol, London SE1 1UL, England.
Bianco, Isaac H., UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England.
Chiapello, Marco, Univ Cambridge, Cambridge Ctr Prote, Cambridge Syst Biol Ctr, Dept Biochem, Cambridge CB2 1QR, England.
Feret, Renata; Deery, Michael J., CNR, Inst Sustainable Plant Protect, I-10135 Turin, Italy.
Carretero-Rodriguez, Luis, Okinawa Inst Sci & Technol Grad Univ, Onna, Okinawa 9040495, Japan.},
 affiliations = {University of Sussex; University of London; King's College London;
University of London; University College London; University of
Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto per la
Protezione Sostenibile delle Piante (IPSP-CNR); Okinawa Institute of
Science & Technology Graduate University},
 author = {Carretero-Rodriguez, Luis and Gudjonsdottir, Ragnheidur and Poparic,
Ivana and Reilly, Madeline Louise and Chol, Mary and Bianco, Isaac H.
and Chiapello, Marco and Feret, Renata and Deery, Michael J. and
Guthrie, Sarah},
 author-email = {s.guthrie@sussex.ac.uk},
 cited-references = {Alam Muhammad S, 2018, Curr Protoc Immunol, V123, pe58, DOI 10.1002/cpim.58.
Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200.
Asakawa K, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00100.
Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457.
Baskaran P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196528.
Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255.
Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004.
Burzynski GM, 2009, GENE EXPR PATTERNS, V9, P231, DOI 10.1016/j.gep.2008.12.010.
Chauvin S, 2015, PROG NEUROBIOL, V126, P1, DOI 10.1016/j.pneurobio.2014.09.002.
Chilton JK, 2017, DEV NEUROBIOL, V77, P861, DOI 10.1002/dneu.22477.
Clark C, 2013, J NEUROSCI, V33, P16540, DOI 10.1523/JNEUROSCI.1869-13.2013.
Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200.
Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P5505, DOI 10.1167/iovs.07-0772.
Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P194, DOI 10.1167/iovs.06-0632.
Devaux S, 2012, J BIOL CHEM, V287, P22341, DOI 10.1074/jbc.M112.344044.
Dumars S, 2008, J AAPOS, V12, P381, DOI 10.1016/j.jaapos.2008.01.018.
Ferrario JE, 2012, P NATL ACAD SCI USA, V109, P14669, DOI 10.1073/pnas.1116481109.
Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825.
Gross-Thebing T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0055-7.
Huang MYY, 2011, ANN NY ACAD SCI, V1233, P285, DOI 10.1111/j.1749-6632.2011.06150.x.
Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972.
Katori S, 2017, J NEUROSCI, V37, P7682, DOI 10.1523/JNEUROSCI.3123-16.2017.
KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302.
Lerner O, 2010, DEV NEUROBIOL, V70, P549, DOI 10.1002/dneu.20796.
Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3.
Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390.
Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x.
Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121.
Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295.
Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165.
Nugent AA, 2017, J CLIN INVEST, V127, P1664, DOI 10.1172/JCI88502.
O'Brien Georgeann S, 2009, J Vis Exp, DOI 10.3791/1129.
Patten SA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.97152.
Pollerberg GE, 2013, MECH DEVELOP, V130, P359, DOI 10.1016/j.mod.2012.11.002.
Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13.
Serra A, 2012, ANN NY ACAD SCI, V1275, P129, DOI 10.1111/j.1749-6632.2012.06841.x.
Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004.
Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032.
Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055.
Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644.
Thisse B, 2004, METHOD CELL BIOL, V77, P505.
Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x.
Whitman MC, 2018, INVEST OPHTH VIS SCI, V59, P5201, DOI 10.1167/iovs.18-25190.
Whitman MC, 2017, HUM MOL GENET, V26, pR37, DOI 10.1093/hmg/ddx168.
Wolman MA, 2007, J NEUROSCI, V27, P9653, DOI 10.1523/JNEUROSCI.1741-07.2007.
Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750.
Yip YY, 2014, BIOCHEM BIOPH RES CO, V446, P248, DOI 10.1016/j.bbrc.2014.02.101.
Yoshie M, 2006, MOL REPROD DEV, V73, P164, DOI 10.1002/mrd.20408.},
 doi = {10.1523/JNEUROSCI.0983-19.2021},
 journal = {JOURNAL OF NEUROSCIENCE},
 keywords = {ocular motor system; alpha2-chimaerin; chimaerin; CRMP2; stathmin},
 keywords-plus = {AXON GUIDANCE; MICROTUBULE DYNAMICS; PHOSPHORYLATION; ALPHA-2-CHIMAERIN;
GROWTH; ZEBRAFISH; DYSINNERVATION; EXPRESSION; MECHANISM; DEPENDS},
 month = {AUG 4},
 number = {31},
 number-of-cited-references = {48},
 pages = {6652-6672},
 title = {The Rac-GAP alpha2-Chimaerin Signals via CRMP2 and Stathmins in the
Development of the Ocular Motor System},
 type = {Article},
 unique-id = {WOS:000684594500007},
 volume = {41},
 year = {2021}
}

